FDA rejects psychedelic drug MDMA for post-traumatic stress dysfunction
The Meals and Drug Administration on Friday rejected a California drug firm’s request to market the psychedelic drug MDMA mixed with discuss remedy as a therapy for post-traumatic stress dysfunction. The federal drug regulator advised San Jose, California-based Lykos Therapeutics it accomplished a evaluate of the corporate’s utility however wouldn’t approve MDMA, also called ecstasy
Read More